Home / Agencies / FDA / 2025-16629
Final Rule

Advisory Committee; Arthritis Advisory Committee; Termination; Removal From List of Standing Committees

Agency
FDA
Document Number
2025-16629
Published
August 29, 2025
Effective Date
August 29, 2025

Abstract

The Food and Drug Administration (FDA or the Agency) is announcing the termination of the Arthritis Advisory Committee (Committee). Due to that termination, this final rule removes the Committee from the Agency's list of standing advisory committees in 21 CFR 14.100.

Federal Register Source

This document is published by the Office of the Federal Register, National Archives and Records Administration. Access the full regulatory text, preamble, and docket comments below.

View Full Text on FederalRegister.gov →

Opens in new tab · federalregister.gov

Frequently Asked Questions

What is the 2025-16629 Federal Register document?
Document 2025-16629 is a Final Rule published by the Food and Drug Administration in the Federal Register on August 29, 2025, with an effective date of August 29, 2025. The Food and Drug Administration (FDA or the Agency) is announcing the termination of the Arthritis Advisory Committee (Committee). Due to that termination, this final rule removes the Committee from the Agency's list of standing advisory committees in 21 CFR 14.100. View the original at https://www.federalregister.gov/documents/2025/08/29/2025-16629/advisory-committee-arthritis-advisory-committee-termination-removal-from-list-of-standing-committees.
Is document 2025-16629 an economically significant rule?
No. Document 2025-16629 is not classified as economically significant under Executive Order 12866. Economically significant rules require OIRA review and are estimated to have impacts of $100 million or more per year.

Other Rules from FDA

Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products; Withdrawal
Proposed · Nov 2025
Green Innovation GmbH; Filing of Food Additive Petition (Animal Use)
Proposed · Nov 2025
Immunology and Microbiology Devices; Reclassification of Nucleic Acid-Based Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product; Proposed Amendment; Proposed Order; Request for Comments
Proposed · Nov 2025
Regulation Identification Number 0910-AJ05 Medical Devices; Laboratory Developed Tests; Implementation of Vacatur
Final Rule · Sep 2025
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address; Correction
Final Rule · Sep 2025
Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices
Final Rule · Sep 2025
View all Food and Drug Administration rules →

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official state legislatures, IAPP, NCSL, and federal regulatory trackers. See our methodology for details. Retrieved and formatted by PlainRegWatch

Every figure on PlainRegWatch is rendered from curated state legislative and Federal Register source data, no number is typed in by an editor. Figures on this page come from the curated five-category archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Tracker scores and rule counts are curated records in five tracked categories - not enforcement strength, legal advice, a complete inventory of US law, or a live bill-status feed.